Newsroom
In the News
-
06.06.2023
Cellarity Appoints Dr. Gregory J. Moore to Board of Directors
-
04.13.2023
Cellarity Hosts Second Single Cell and AI in Medicine Symposium on May 4, 2023
-
04.11.2023
Cellarity Strengthens Executive Leadership Team
-
10.04.2022
Cellarity Announces Close of $121 Million Series C Financing
-
08.17.2022
Cellarity Releases Novel, Open-Source, Single-Cell Dataset and Invites the Machine Learning and Computational Biology Communities to Develop New Algorithms Capable of Learning Fundamental Rules of Cell Behavior
-
05.09.2022
Cellarity Appoints Dr. Sandra Horning to Board of Directors
-
05.06.2022
Cellarity Hosts First Single Cell and AI in Medicine Symposium on May 19
-
02.10.2022
Cellarity Expands Leadership Team to Continue Evolution of a Breakthrough Platform to Encode Biology and Purposefully Create New Medicines
-
01.06.2022
The Future of Biotech in an Artificially Intelligent World
-
12.08.2021
Cellarity Appoints Biopharmaceutical Executive Ian Estepan to its Board of Directors
-
10.07.2021
5 Up-and-Coming Biotech Startups Worth Watching
-
10.06.2021
Decoding cell behavior and disease with AI and single-cell transcriptomics
-
09.27.2021
Fierce Biotech names Cellarity as one of its “Fierce 15” Biotech Companies of 2021
-
02.25.2021
Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target
-
07.16.2020
Flagship Pioneering Bolsters Executive Team with Appointment of Fabrice Chouraqui in Newly Created Dual Role of Flagship CEO-Partner and CEO of Cellarity
-
12.11.2019
Flagship Pioneering launches Cellarity for cell behaviour-targeting drugs
-
12.11.2019
Flagship’s Cellarity Aims to Advance Cell Behavior-Based Therapeutics
-
12.10.2019
Flagship’s Cellarity maps out network-based drug discovery
-
12.10.2019
Flagship Pioneering Launches New Company to Discover Medicines Targeting Cellular Behavior | BioSpace
-
12.10.2019
Flagship Pioneering's Cellarity Exits Stealth Mode to Discover Drugs Using Cell Behavior
-
12.10.2019
Cellarity, Flagship's $50M bet on Network Biology, Marries Machine Learning and Single-Cell Tech for Drug Discovery
-
12.10.2019
Fierce Biotech | Flagship Company Cellarity Takes Aim at Cell Behavior
-
12.09.2019
Flagship Pioneering Unveils Cellarity, the First Company to Discover Medicines Targeting Cell Behavior
-
10.23.2019
Can Machines Understand Complex Biology?